Notably, we validate the expression of GLP-1 signaling-related genes ITPR1 and ADCY5, as well as the potential protective role of GLP-1 receptor agonist, suggesting a promising strategy for the treatment of CRC. This evidence concerns the gene GCG and colorectal carcinoma.